Criterion validity of the functional status and pain assessment scale versus pain and length of stay in hospitalized adults with SCD

功能状态和疼痛评估量表与镰状细胞病住院成人患者的疼痛和住院时间之间的效标效度

阅读:1

Abstract

OBJECTIVES: In prior research we demonstrated face, construct, discriminant, and preliminary convergent validity of the newly developed, 10-item Functional Status Pain Assessment (FSPA) scale (0-50) in adult SCD patients hospitalized with VOC. We aimed in this study to further demonstrate criterion validity of the FSPA. METHODS: This was a prospective observational study of 561 daily functional and pain assessments from 91 hospitalized adults with SCD from January 2018 to June of 2019. Principal Component Analysis (PCA) Partial Least Squares (PLS) models determined the relationship between LOS, pain intensity, and FSPA. A Generalized Linear Model (GLM) to quantified the impact of changes in pain intensity on LOS. RESULTS: The population mean age was 34 ± 12.2 years, and 59.3% were female. A little over half were genotype SS. Neither admission nor discharge FSPA scores were significant determinants of LOS. Specifically, no component or factor of FSPA score on day of admission explained the LOS. In addition, FSPA score on day of discharge explained only 5.69% of the variance in LOS. Similarly, FSPA score explained only 19.66% of the variance in pain intensity on any pain day. There was no relationship between LOS and pain intensity changes from admission to discharge (P = .92). CONCLUSIONS: The FSPA score did not demonstrate criterion validity with respect to NRS pain intensity changes from admission to discharge, nor to the LOS for SCD admissions. Instead, unmeasured, perhaps environmental, psychosocial, and economic variables, exerted a far more substantial influence on hospital LOS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。